Clinical Trials Browser

Phase 3 × Not yet recruiting × Denosumab × Clear all

NCT06314698 2024-03-18

Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease

Phase 3 Not yet recruiting

Bone Diseases, Multiple Myeloma

NCT05813665 2023-04-19

A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone

Phase 3 Not yet recruiting

Giant Cell Tumor of Bone